As I told you, one of my closest friends was at JFK on Wed. He spoke face to face with Tony and Barry and the few staff that were there. Others were at Willow. This is what he told me: (Lt's post is more current than the info. my friend received but everything else I am saying you already know). Baltia is a real company. They have an office at JFK that is very nice and people are working. There are empty seats that will be filled upon certification i.e. flight dispatcher and many other positions that require some of their planes to be flying routes. The company was told at the meeting in DC in Sept. they will hear "soon". Same thing we keep hearing. Unfortunately Baltia could not get a definition of soon. They were advised not to push or prod the FAA because it will not help. Nobody likes to be passive but apparently it's not to their benefit to call everyday and say "what's going on guys where is our decision." They really want to do that and they really want to put out a PR but unfortunately they can't. You all know why whether it makes sense or not. My friend got the feeling by talking with them that they are extremely excited for the future and are even more impatient than every single one of us shareholders or possibly all of us combined. You may be dreaming of $10s or $100s of thousands and possibly a few million. Baltia as a company are dreaming of $100s of millions and Billions although they did not say that directly. They just told them where they expect to be as a company upon certification. They reiterated to my friend that their plan is not to fly one plane around and make money just with the existing 747. Their plan is to expand their fleet and target areas in the US. where Eastern European populations and travel to that region is expanding. Unfortunately, they did not mention a secret mini or R1 deployment unless something changed since Wed. When they get the word, they will be ready and we will know almost instantly. They will sprint full speed to the PR machine. Despite what some people are saying on both boards, they care very much for the shareholders and know our frustrations more than you can imagine. They couldn't be more aware if you beat each of them on the head with a hammer. They want for us what they want for themselves. Proving flights, cert. and a massive expansion in a business with very high barriers to entry. All that will lead to $$$$ for all. On a final note, they did not specify how, but upon certification, they believe financing expansion will not be an issue. You know all this already. Just read spekulator's posts. There's nothing more they can say other than "still waiting". Thankfully LT's post gives us hope that things are speeding up. I do not speak for the company. Just sharing his experience and thoughts as were told to me.
Introduction to Scilex Holding Company
Pioneering company Scilex Holding Company (Nasdaq: SCLX) is concentrated on the development and marketing of non-opioid pain management solutions. Dedicated to enhancing patient quality of life, Scilex seeks to lead the worldwide pain management solution market. To guarantee responsible pharmaceutical development, the company operates under tight social, environmental, financial, and ethical standards.
Overview of the Master Distributor Agreement
B... Continue Reading
Overview of Above Food's Strategic Acquisition
Leading food company known for its vertically integrated supply chain, Above Food Ingredients Inc. (Nasdaq: ABVE, ABVE.W), has said a major US expansion with the acquisition of The Redwood Group, LLC's Specialty Crop Food Ingredients Division. valued at $34 million, this calculated action consists of 5.6 million recently issued common shares of Above Food combined with $8.1 million in cash. Following usual closing criteria and final adjus... Continue Reading
Hurco and Kawasaki Robotics Join Forces
Leader in CNC machine and control technology Hurco Companies, Inc. (Nasdaq: HURC) has announced a strategic alliance with respected producer of industrial robotics and automation systems Kawasaki Robotics (USA, Inc.). Leveraging over 50 years of Hurco's knowledge in CNC machine tools and controls and Kawasaki's vast industrial robotics expertise, this collaboration combines the strengths of both companies. Taken together, they seek to provide tu... Continue Reading
Introduction to Mangoceuticals’ Innovative Approach
With the release of its recently created DEA-approved telemedicine operating system, Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx") has reached a turning point. The company's goal of providing creative men's health and wellness products—including solutions for erectile dysfunction (ED), hair growth, weight loss, and hormone replacement therapies—is much advanced by this development. MangoRx is dedicated ... Continue Reading
Category: StocksTotal Views: 224 By : Ryan HughesUpdated: 08-11-2024
Introduction to ANEW Medical, Inc.
Pioneering biopharmaceutical company ANEW Medical, Inc. (NASDAQ: WENA) is committed to create creative, disease-modifying treatments aiming at the brain and central nervous system (CNS). Among the most difficult neurodegenerative diseases the company targets are Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS), and several types of cancer. By means of innovative research and development, ANEW Medical seeks to fulfill major unmet medical ... Continue Reading
Senior Convertible Debt Agreement with Accredited Institutional Investor
Webuy Global Ltd. (Nasdaq: WBUY) announced a new senior convertible debt agreement with an initial principal amount of $2 million. The company could be able to get an extra $4 million, subject to mutual agreement with the accredited institutional investor engaged. Set at $0.213 per share, which is 150% of the company's Class A ordinary shares' volume-weighted average price (VWAP) on the trading day before the not... Continue Reading
The Strategic Importance of Gevo's Net-Zero 1 Facility
Based on a key analysis by Charles River Associates (CRA), Gevo, Inc. (NASDAQ: GEVO) has revealed the major environmental and financial advantages linked with the manufacturing of sustainable aviation fuel (SAF). With a thorough examination of the possible effects, this paper centers on Gevo's intended Net-Zero 1 (NZ1) alcohol-to---jet (ATJ) SAF facility in South Dakota. CRA's research shows that every dollar spent through fed... Continue Reading
Category: StocksTotal Views: 256 By : Caleb PriceUpdated: 08-10-2024
FDA Approves Neffy® Nasal Spray for Severe Allergic Reactions
Leading biopharmaceutical developer of treatments for severe allergic reactions, ARS Pharmaceuticals, Inc. (Nasdaq: SPRY) reached a major turning point with FDA approval of neffy® (epinephrine nasal spray) 2 mg. Now approved for use in adults and children weighing 66 pounds or more experiencing Type I Allergic Reactions, including potentially fatal anaphylaxis, this novel treatment is First needle-free epinephrine delivery ... Continue Reading
Category: StocksTotal Views: 350 By : Riley HayesUpdated: 08-10-2024
Introduction to OneMedNet Corporation
Leading curating and managing of regulatory-grade Real World Data (RWD) is OneMedNet Corporation (Nasdaq: ONMD). By including its own artificial intelligence technology into its data curating procedures, the company has lately made a big advance. Along with simplifying the de-identification of patient data, this invention significantly cut running expenses. OneMedNet has improved its capacity to process enormous volumes of clinical data by using artificia... Continue Reading
Symbotic Expands Capabilities with Strategic Acquisition
Leader in A.I.-enabled robotics technology Symbolic Inc. (Nasdaq: SYM) has made a big advance by acquiring Veo Robotics' assets. This purchase seeks to improve Symbotic's capacity for field-based industrial automation innovation, especially in settings where humans and robots collaborate. By including Veo Robotics' FreeMove® 3D vision system, Symbolic will be able to guarantee worker safety while raising output. Bringing... Continue Reading